Search research articles
Contact Us
Filters
Showing results (151-160 of 191) with videos related to
Page
of 20
Sort By:
Annals of Hematology
|
July 6, 2021
Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms
Le Yin, Sisi Xie, Yi Chen, et al.
Ecotoxicology and Environmental Safety
|
September 25, 2021
Perfluorooctane sulfonate affects mouse oocyte maturation in vitro by promoting oxidative stress and apoptosis induced bymitochondrial dysfunction
Kang-Na Wei, Xin-Jie Wang, Zhao-Cheng Zeng, et al.
Journal of Drug Targeting
|
June 3, 2016
New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes
Shi-Jie Gao, Yang Liu, Han-Jie Wang, et al.
Military Medical Research
|
November 8, 2021
The roles of exosomal immune checkpoint proteins in tumors
Cheng Xing, Heng Li, Rui-Juan Li, et al.
Thrombosis Research
|
August 13, 2016
Two novel compound heterozygous mutations associated with types I and II protein C deficiency with unusual phenotypes
Ming-Yang Deng, Zi-Xian Liu, Hai-Fan Huang, et al.
Frontiers in Oncology
|
October 10, 2022
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling
Yang Zhang, Zhihua Wang, Guoyu Hu, et al.
Nucleic Acids Research
|
December 12, 2017
USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1
Zengxia Li, Zhao Cheng, Chaerkady Raghothama, et al.
Cell Death & Disease
|
September 11, 2020
A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1<sup>-</sup> pre-B-ALL
Zhihua Wang, Yang Zhang, Shicong Zhu, et al.
Ebiomedicine
|
October 10, 2019
Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway
Yiyi Liu, Qingping Jiang, Xiong Liu, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 24, 2022
HIF-PH Encoded by <i>EGLN1</i> Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia
Wancheng Guo, Daomiao Liang, Peilong Wang, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 191) with videos related to
Sort By:
Page
of 20
Annals of Hematology
|
July 6, 2021
Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms
Le Yin, Sisi Xie, Yi Chen, et al.
Ecotoxicology and Environmental Safety
|
September 25, 2021
Perfluorooctane sulfonate affects mouse oocyte maturation in vitro by promoting oxidative stress and apoptosis induced bymitochondrial dysfunction
Kang-Na Wei, Xin-Jie Wang, Zhao-Cheng Zeng, et al.
Journal of Drug Targeting
|
June 3, 2016
New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes
Shi-Jie Gao, Yang Liu, Han-Jie Wang, et al.
Military Medical Research
|
November 8, 2021
The roles of exosomal immune checkpoint proteins in tumors
Cheng Xing, Heng Li, Rui-Juan Li, et al.
Thrombosis Research
|
August 13, 2016
Two novel compound heterozygous mutations associated with types I and II protein C deficiency with unusual phenotypes
Ming-Yang Deng, Zi-Xian Liu, Hai-Fan Huang, et al.
Frontiers in Oncology
|
October 10, 2022
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling
Yang Zhang, Zhihua Wang, Guoyu Hu, et al.
Nucleic Acids Research
|
December 12, 2017
USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1
Zengxia Li, Zhao Cheng, Chaerkady Raghothama, et al.
Cell Death & Disease
|
September 11, 2020
A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1<sup>-</sup> pre-B-ALL
Zhihua Wang, Yang Zhang, Shicong Zhu, et al.
Ebiomedicine
|
October 10, 2019
Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway
Yiyi Liu, Qingping Jiang, Xiong Liu, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 24, 2022
HIF-PH Encoded by <i>EGLN1</i> Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia
Wancheng Guo, Daomiao Liang, Peilong Wang, et al.
Page
of 20